Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
															Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





Current Intelligence Bulletin 30: Epichlorohydrin										Related Pages
										October 12, 1978
DHHS (NIOSH) Publication Number 79-105
Epichlorohydrin
The National Institute for Occupational Safety and Health (NIOSH) recommends that as a prudent measure, epichlorohydrin be handled in the workplace as if it were a human carcinogen. This recommendation is based primarily on two recent studies: a long term epidemiologic study showing significant increase in respiratory cancer deaths of exposed workers, and an inhalation study showing an increase in nasal carcinomas in rats. In addition, cytogenic studies of human peripheral lymphocytes have shown a highly significant increase in chromosome abnormalities in exposed workers. Pending further evaluation of its carcinogenic potential, NIOSH believes it would be prudent to minimize occupational exposure to epichlorohydrin.
NIOSH has prepared this Bulletin to advise you of these recent studies, their implications for occupational health, and precautions for handling products containing epichlorohydrin. We request that producers, distributors, and users transmit this information to their customers and employees, and that professional associations and unions inform their members.

Exposure Standards
The current Department of Labor, Occupational Safety and Health Administration (OSHA) standard for occupational exposure to epichlorohydrin is 5 ppm (19 mg/cu m) as an 8-hour time-weighted average.1 Studies of carcinogenicity were not available when this standard was developed.
In September 1976, NIOSH recommended an occupational exposure limit of 2 mg/cu m of air (approximately 0.5 ppm) determined as a time-weighted average (TWA) concentration for up to a 10 hour work day in a 40 hour work week, and a ceiling concentration standard of 19 mg/cu m (approximately 5 ppm) as determined by a sampling time of 15 minutes.2 After a comprehensive review of the literatures NIOSH concluded that risks from exposure to epichlorohydrin may include carcinogenesis, mutagenesis and sterility, as well as damage to the kidneys, liver, respiratory tract, and skin. Since most of the evidence on adverse effects of epichlorohydrin was obtained from animal experiments which were inadequate to determine scientifically acceptable exposure limits, the 1976 NIOSH recommendation was based on professional judgement which quantitatively considered the cumulative toxic effects.

Production, Uses, and Occupational Exposures
Epichlorohydrin is a liquid at room temperatures. In 1978, domestic annual production capacity was 470 million pounds. An important constituent of epoxy resin is synthesized by alkylating bisphenol A with epichlorohydrin.2 Epichlorohydrin is used in the manufacture of epoxy resins, surface active agents, pharmaceuticals, insecticides, agricultural chemicals, textile chemicals, coatings, adhesives, ion-exchange resins, solvents, plasticizers glycidyl esters, ethynylethylenic alcohol and fatty acid derivatives.
According to the NIOSH National Occupational Hazard Survey (NOHS),3 an estimated 85,000 workers are potentially exposed to epichlorohydrin in the workplace. Table 1 lists occupations and industries in which a potential exists for exposure to epichlorohydrin. The NOHS survey data were collected during 1972 to 1974 from a sample of approximately 5,000 businesses employing nearly 900,000 workers. 1970 Census figures were used in extrapolating the sample data to the working population employed in industries covered by the Occupational Safety and Health Act of 1970. The potential exposure estimates include data on actual observations of the use of the specific chemical or the use of a trade name product known to contain the chemical as well as additional observations of generic formulations (trade name products suspected of containing the chemical).

**Table 1.** Some Occupations and Industries Which Use Epichlorohydrin
Some Occupations and Industries Which Use Epichlorohydrin
Occupations a
assemblers; miscellaneous specified machine operatives; aircraft machinists; construction and maintenance painters; miscellaneous operatives; chemists; mining operatives; painters of manufactured articles; sheetmetal workers and tinsmiths; pattern and model matters except paperIndustries b
chemicals and allied products; transportation equipment; instruments and related products; transportation by air; electrical equipment and supplies; special trade contractors; miscellaneous repair services; rubber and plastics not elsewhere classified; machinery, except electrical; stone, clay, and glass products(a) Standard occupational titles from the Bureau of the Census4 (b) Standard Industrial titles from the *Standard Industrial Classification Manual.*5

Human Carcinogenicity
A statistically significant (p<.05 increase in deaths due to respiratory cancer has been observed in a long-term epidemiologic study conducted on workers exposed to epichlorohydrin at two facilities of the Shell Chemical Company.6 The data were analyzed by Dr. Philip Enterline of the University of Pittsburgh.7,8 There were 864 workers identified as having been occupationally exposed to epichlorohydrin for 6 months or more, before January 1, 1966. Ninety-eight percent of the workers were traced as of December 31, 1976. For men estimated to have had moderate to heavy exposure who were followed for 15 years or more, observed deaths were also greater than those expected for the categories of all cancers, leukemia, and suicide, although those differences were not statistically significant. Information was not available for most workers on smoking history, or the extent of exposure to other chemicals.9 NI0SH feels that the study results are suggestive of a carcinogenic effect of epichlorohydrin on humans, and deserve attention.
The Dow Chemical Company has informed NIOSH that it is currently conducting a mortality study of workers engaged in the manufacture and conversion of epichlorohydrin.10 Dow estimates that the results will be made available November, 1978.

Animal Carcinogenicity
In ongoing inhalation studies, rats exposed to epichlorohydrin have shown a statistically significant increase in nasal cancer (p <.05).11 In experiments initiated under Dr. Sidney Laskin and continued under Dr. Norton Nelson at the New York University Institute of Environmental Medicine, 140 rats have been exposed to 100 ppm epichlorohydrin for 6 hours/day, 5 days/week, for 30 days, with subsequent lifetime observation. Fifteen of the animals have died with pathologically confirmed squamous cell nasal cancinoma.11 Another animal developed a nasal papilloma. No spontaneous nasal cancer was seen in a group of 50 controls. Of another group of 100 animals exposed to 30 ppm of epichlorohydrin for 6 hours/day, 5 days/week, in a chronic lifetime study one animal has developed a papilloma of the larynx, another has developed a nasal squamous cell carcinoma.12 In contrast, no spontaneous nasal carcinomas were seen in the 50 animal control group.
Further information on previous studies that investigated the other evidence relating to carcinogenicity of epichlorohydrin can be found in the NIOSH epichlorohydrin criteria document.2,13

Human Mutagenicity
Epichlorohydrin has been shown to induce a significant increase in chromosomal aberrations found in the white blood cells of workers occupationally exposed to epichlorohydrin. In 1979 Kucerova *et al.*14 conducted a prospective cytogenetic study of 35 workers occupationally exposed to epichlorohydrin. Each worker served as his own control. After exposure for one year, these workers showed a significant increase in chromosomal aberrations. After two years of exposure to epichlorohydrin, the increase in chromosomal aberrations was significant at the p <.0001 level.
In 1976, Sram *et al*.15 found chromosome abnormalities in human peripheral lymphocytes exposed *in vitro* to epichlorohydrin. They concluded that a genetic risk for man exists following exposure to epichlorohydrin. A quantitative risk was not estimated.

Other Toxic Effects
Epichlorohydrin is a highly toxic substance which is easily absorbed through the skin. Skin contact with epichlorohydrin can cause severe chemical burns, although the effects may not appear until sometime after exposure. The latent period can range from several minutes to several days, depending on the duration and intensity of exposure. Allergic response has been noted.16 Exposure to epichlorohydrin vapor induces transient burning of the eyes and nasal passages at concentrations as low as 20 ppm. Exposure to high concentrations (100 ppm) leads to pulmonary edema (fluid accumulation in the lung) and kidney problems in laboratory animals. A comprehensive discussion of the toxic effects is found in the NIOSH epichlorohydrin criteria document. Table 2 summarizes the reported toxic effects in humans at varying exposure levels.

**Table 2.** Other Toxic Effects of Epichlorohydrin on Humans.2
Other Toxic Effects of Epichlorohydrin on Humans
Route of
Exposure
Effectdermal
burning sensation, redness, swelling, red papules, itching, blisters, skin erosion, enlarged lymph nodesinhalation
burning of the eyes, nose and throat; cough; chest congestion; running nose; eye tenderness; headache followed by nausea; vomiting; facial swelling; dyspneaExposure to epichlorohydrin has been shown to induce sterility in rats,2 and a fertility study has been conducted in male workers exposed to epichlorohydrin.17 While the study concluded that exposure to epichlorohydrin did not decrease sperm counts or affect hormonal activity in the workers, the data were not analyzed statistically.

NIOSH Recommendations
In light of the statistically significant increase in respiratory cancer seen in workers exposed to epichlorohydrin, and the statistically significant increase in nasal carcinomas seen in rat inhalation studies, as well as the chromosomal aberrations seen in the peripheral lymphocytes of exposed workers, NIOSH recommends that epichlorohydrin be treated in the workplace as if it were a human carcinogen. Pending further evaluation of its carcinogenic potential NIOSH believes it would be prudent to minimize occupational exposure to epichlorohydrin. Exposures should be limited to as few employees as possible while workplace exposure should be minimized with engineering and work practice controls. In particular, skin exposure should be avoided.
*[signature]*
J. Michael Lane, M.D.
Acting Director

References
U.S. Department of Labor, Occupational Safety and Health Administration: *Occupational Safety and Health General Industry Standards.* Publication 2206, 29 CFR 1910-1000, Washin ton, D.C. (1976)
U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Controling National Institute for Occupational Safety and Health. *Criteria for a Recommended Standard .... Occupational Exposure to Epichlorohydrin.* Washington, D.C. (1976).
NIOSH National Occupational Hazard Survey (NOHS): Personal communication to the NIOSH Technical Evaluation and Review Branch, Office of Extramural Coordination and Special Projects (1978).
U.S. Bureau of the Census: *1970 Census of Population, Alphabetical Index of Industries and Occupations.* Washington, D.C. (1971).
Bureau of the Budget: *Standard Industrial Classification Manual.* Washington, D.C. (1967).
Enterline, P.: Letter from P. Enterline, Ph.D., Department of Biostatistics, University of Pittsburgh to R. E. Joyner, M.D., Corporate Medical Director, Shell Oil Company, July 31, 1978.
Enterline, P.: Updated Mortality in Workers Exposed to Epichlorohydrin, unpublished report to the Shell Oil Company, July 31, 1978.
Enterline, P.: Mortality in Workers Exposed to Epichlorohydrin, unpublished report to the Shell Oil Company, August 31, 1977.
Joyner, R.E.: Letter from R.E. Joyner, M.D., Corporate Medical Director, Shell Oil Company to J. Michael Lane, M.D., Acting Director, NIOSH, August 7, 1978.
Walker, R.C.: Letter from R.C. Walker, Manager, The Dow Chemical Company, to Vernon E. Rose, Ph.D., Director, Division of Criteria Documentation and Standards Development, NIOSH, August 29, 1978.
New York University Institute of Environmental Medicine: Personal communication to the NIOSH Technical Evaluation and Review Branch, Office of Extramural Coordination and Special Projects, (1978).
Nelson, N.: Letter to the Office of the Director, NIOSH, June 23, 1978, updating the letter of March 28, 1977.
Van Duuren, B.B., B. M. Goldschmidt, C. Katz, I. Seidman, and J. S. Paul: Carcinogenic Activity of Alkylating Agents. *Journal of the National Cancer Institute 53*: 695-700 (1974).
Kucerova, M., V. S. Zurkov, Z. Polvkova, and J. E. Ivanova: Mutagenic Effect of Epichlorohydrin. II. Analysis of Chromosol Aberrations in Lymphocytes of Persons Occupationally Exposed to Epichlorohydrin. *Mutation Research, 48*: 355-360 (1977).
Sram, R.J., M. Cerna, and M. Kucerova: The Genetic Risk of Epichlorohydrin as Related to the Occupational Exposure. *Biologisches Zentralblatt 95*: 451- 462 (1976).
U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health: *Occupational Diseases: A Guide to Their Recognition*. Washington, D.C. (1977).
Whorton, D., T.H. Milby, and R.L. Davis: Testicular Function Among ECH Workers at Shell Deer Park and Norco Facilities. Unpublished report to the Shell Oil Company from Environmental Health Associates, August 22, 1978.
Suggested Guidelines for Monitoring and Controlling Employee Exposure to Epichlorohydrin
NIOSH recommends that it would be prudent to handle epichlorohydrin in the workplace as if it were a human carcinogen. Exposure to epichlorohydrin should be limited to as few employees as possible, and workplace exposure levels should be minimized. The area in which it is used should be restricted to only those employees essential to the process or operation and these employees should be adequately protected.

Exposure Monitoring
A detailed sampling, and analytical method for epichlorohydrin exposure measurements is described in the *NIOSH Manual of Analytical Methods, Second Edition*1 as NIOSH method #S118 in Volume 2.
Initial and routine employee exposure surveys should be made by competent industrial hygiene and engineering personnel. These surveys are necessary to determine the extent of employee exposure and to ensure that controls are effective.
The *NIOSH Occupational Exposure Sampling Strategy Manual*,2 may be helpful in developing efficient programs to monitor employee exposures to epichlorohydrin. The manual discusses determination of the need for exposure measurements selection of appropriate employees for exposure evaluation and selection of sampling times.
Employee exposure measurements should primarily consist of 8-hour TWA (time-weighted average) exposure estimates calculated from personal or breathing zone samples (air that would most nearly represent that inhaled by the employees). In addition, short term samples should be taken during periods of maximum expected exposure by using all available knowledge regarding the area, employee work procedures, and process. Area and source measurements may be useful to determine problem areas, processes, and operations.

Controlling Employee Exposure
There are four basic methods of limiting employee exposure to epichlorohydrin. None of these is a simple industrial hygiene or management decision and careful planning and thought should be used prior to implementation.
**Product Substitution**
The substitution of an alternative material with a lower potential health risk is one method. However, extreme care must be used when selecting possible substitutes. Alternatives to epichlorohydrin should be fully evaluated with regard to possible human effects. Unless the toxic effects of the alternative have been thoroughly evaluated a seemingly safe replacement, possibly only after years of use, may be found to induce serious health effects.
**Contaminant Controls**
The most effective control of epichlorohydrin where feasible, is at the source of contamination by enclosure of the operation and/or local exhaust ventilation. Guidelines for selected processes and operations can be found in the NIOSH Recommended Industrial Ventilation Guidelines.3If feasible, the process or operation should be enclosed with a slight vacuum so that any leakage will result in the flow of external air into the enclosure.The next most effective means of control would be a well designed local exhaust ventilation system that physically encloses the process as much as possible, with sufficient capture velocity to keep the contaminant from entering the work atmosphere.
To ensure that ventilation equipment is working properly, effectiveness (e.g., air velocity, static pressure or air volume) should be checked at least every three months. System effectiveness should be checked soon after any change in production, process, or control which might result in significant increases in airborne exposure to epichlorohydrin.
**Employee Isolation**
A third alternative is the isolation of employees. It frequently involves the use of automated equipment operated by personnel observing from a closed control booth or room. The control room is maintained at a greater air pressure than that surrounding the process equipment so that air flow is out of, rather than into, the room. This type of control will not protect those employees that must do process checks, adjustments maintenance and related operations.
**Personal Protective Equipment**
The least preferred method is the use of personal protective equipment. This equipment which may include respirators goggles, gloves, etc., should not be used as the only means to prevent or minimize exposure during routine operations.Exposure to epichlorohydrin should not be controlled with the use of respirators except:
During the time period necessary to install or implement engineering or work practice controls; or
In work situations in which engineering and work practice controls are technically not feasible; or
For maintenance; or
For operations which require entry into tanks or closed vessels; or
In emergencies.Only respirators approved by the National Institute for Occupational Safety and Health (NIOSH) under the provisions of Federal regulations 30 CFR 11 should be used. Refer to Cumulative Supplement June 1977, NIOSH Certified Equipment4 for a listing of NIOSH-approved respirators. Note that the use of faceseal coverlets or socks with respirators voids NIOSH approvals.
Quantitative faceseal fit test equipment (such as sodium chloride, dioctyl phthalate, or equivalent) should be used. Refer to NIOSH’s A Guide to Industrial Respiratory Protection5 for guidelines on appropriate respiratory protection programs.
In addition, proper maintenance procedures, good housekeeping in the work area, and employee education are all vital aspects of a good control program. Employees should be informed as to the nature of the hazard, its control, and appropriate personal hygiene procedures.

References for Suggested Guidelines
*NIOSH Manual of Analytical Methods*, 2nd Edition, Vol. 1: GPO #017-033-00267-3, $8.75: Vol. 2: GPO #017-033-00260-6, $9.75: Vol. 3: GPO #017-033-0247-9, $9.00.
*NIOSH Occupational Exposure Sampling Strategy Manual*, GPO #017-033-00247-9, $2.75.
*NIOSH Recommended Industrial Ventilation Guidelines*, GPO #017-033-00136- 7, $3.90.
*NIOSH Cumulative Supplement June 1977, NIOSH Certified Equipment*, NIOSH #77-195, no charge.
*A Guide to Industrial Respiratory Protection*, GPO #017-033-00153-7, $2.30.References for Suggested Guidelines
GPO publications must be ordered from:
Superintendent of Documents
U.S. Government Printing Office
Washington, D.C. 20402Reference #4 can be ordered from:
Publications Dissemination, DTS
NIOSH
4676 Columbia Parkway
Cincinnati, Ohio 45226
Identifiers and Synonyms for Epichlorohydrin
Chemical Abstracts Service Registry Number: 106-89-8
NIOSH RTECS Number: TX4900000
Chemical Formula: C3H5OCl
Identifiers and Synonyms for Epichlorohydrin
1-Chloro-2,3-epoxypropane
Epichlorohydrin3-Chloro-1,2-epoxypropane
*a*-Epichlorohydrin3-Chloro-1,2-propylene oxide
1,2-Epoxy-3-chloropropane(Chloromethyl)ethylene oxide
2,3-Epoxypropyl chloride(Chloromethyl)oxirane
Glycerol epichlorohydrin2-Chloromethyl oxyrane
Glycidyl chloride3-Chloropropene-1,2-oxide
Oxirane, (chloromethyl)-Chloropropylene oxide
Oxirane, 2-(Chloromethyl)-*y*-Chloropropylene oxide
Propane, 1-chloro-2,3-epoxy-ECH
SKEKhGECHH
Cumulative List of NIOSH Current Intelligence Bulletins
Cumulative List of NIOSH Current Intelligence Bulletins
1. Chloroprene
January 20, 19752. Trichloroethylene (TCE)
June 6, 19753. Ethylene Dibromide (EDB)
July 7, 19754. Chrome Pigment
June 24, 1975
October 7, 1975
October 8, 19765. Asbestos – Asbestos Exposure during Servicing of Motor Vehicle Brake and Clutch Assemblies
August 8, 19756. Hexamethylphosphoric Triamide (HMPA)
October 24, 19757. Polychlorinated Biphenyls (PCBS)
November 3, 1975
August 209 19768. 4,4′-Diaminodiphenylmethane (DDM)
January 30, 19769. Chloroform
March 15, 197610. Radon Daughters
May 11, 197611. Dimethylcarbamoyl Chloride (DECC) Revised
July 7, 197612. Diethylcarbamoyl Chloride (DECC)
July 7. 197613. Explosive Azide Hazard
August 16, 197614. Inorganic Arsenic – Respiratory Protection
September 27,197615. Nitrosamines in Cutting Fluids
October 6, 197616. Metabolic Precursors of a Known Human Carcinogen, Beta-Naphthylamine
December 17, 197917. 2-Nitropropane
April 25, 197718. Acrylonitrile
July 1, 197719. 2,4-Diaminoanisole in Hair and Fur Dyes
January 13, 197820. Tetrachloroethylene (Perchloroethylene)
January 20, 197821. Trimellitic Anhydride (TMA)
February 3, 197822. Ethylene Thiourea (ETU)
April 11, 197823. Ethylene Dibromide and Disulfiram Toxic Interaction
April 11, 197824. Direct Black 38, Direct Blue 6, and Direct Brown 95 Benzidine Derived Dyes
April 17, 197825. Ethylene Dichloride (1,2-Dichloroethane)
April 19, 197826. NIAXI Catalyst ESN
May 22, 197827. Chloroethanes – Review of Toxicity
August 21, 197828. Vinyl Halides – Carcinogenicity
September 21,197829. Glycidyl Ethers
October 12, 197830. Epichlorohydrin
October 12, 1978
							
					
						Page last reviewed:  June 6, 2014					Content source: 	National Institute for Occupational Safety and Health homeNIOSH Publications & Products
NIOSH-Issued Publications
Search NIOSHTIC-2 Research Database
Docket
Documents for Public Review
Peer Review Agenda
Databases
eNews
Federal Register Noticesplus icon
FRN Archive 2007-2010
FRN Archive 2005-2006
FRN Archive 2001-2004
FRN Archive 1996-2000
Press Releases and Updatesplus icon
Press Release Archives 2010-2013
Press Release Archives 2006-2009
Press Release Archives 2001-2005
Press Release Archives 1998-2000
Press Release Archives 1992-1997
Regulations
Regulatory Agenda
Science Blog
Software
Video Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue